Literature DB >> 6604070

Infection caused by thymidine-requiring, trimethoprim-resistant bacteria.

C H King, D M Shlaes, M J Dul.   

Abstract

We first noted the appearance of thymidine-requiring, gram-negative bacilli in clinical specimens 2 years ago. Since then we have seen 10 patients colonized or infected with these organisms. These strains do not grow on Mueller-Hinton media, growth on MacConkey agar is variable, and growth in API 20E (Analytab Products) and Enterobacteriaceae-Plus Cards (AutoMicrobic system; Vitek Systems Inc.) is inadequate for reliable identifications. Thymidine-requiring organisms are routinely resistant to sulfonamides and trimethoprim. Infection or colonization is associated with previous sulfamethoxazole-trimethoprim therapy in most cases. Of 10 patients, 1 had septicemia of urinary tract origin, 5 had urinary tract colonization or infection, 2 had wound colonization, and two had colonization of respiratory secretions. Thymidine-requiring, gram-negative bacilli can be pathogens and present potential problems in diagnosis, identification, and susceptibility testing.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604070      PMCID: PMC270747          DOI: 10.1128/jcm.18.1.79-83.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  A new dihydrofolate reductase with low trimethoprim sensitivity induced by an R factor mediating high resistance to trimethoprim.

Authors:  O Sköld; A Widh
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

2.  Thymidine-dependent Escherichia coli infection and some associated laboratory problems.

Authors:  E I Tanner; C H Bullin
Journal:  J Clin Pathol       Date:  1974-07       Impact factor: 3.411

3.  Thymine dependent strains of Escherichia coli selected by trimethoprim-sulphamethoxazole therapy.

Authors:  J W Tapsall; E Wilson; J Harper
Journal:  Pathology       Date:  1974-04       Impact factor: 5.306

4.  Joint trimethoprim and sulphamethoxazole resistance in bacteria infected with R factors.

Authors:  R J Pinney; J T Smith
Journal:  J Med Microbiol       Date:  1973-02       Impact factor: 2.472

5.  Characteristics of some co-trimoxazole-resistant Enterobacteriaceae from infected patients.

Authors:  J Barker; D Healing; J G Hutchison
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

6.  Use of trimethoprim to obtain thymine-requiring mutants of Streptococcus faecalis.

Authors:  M H Andrew
Journal:  J Gen Microbiol       Date:  1973-01

7.  Letter: Is co-trimoxazole bactericidal in sputum?

Authors:  R W Lacey; E Lewis
Journal:  Br Med J       Date:  1973-10-20

8.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

9.  Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media.

Authors:  A E Koch; J J Burchall
Journal:  Appl Microbiol       Date:  1971-11

10.  Trimethoprim resistance determined by R factors.

Authors:  M P Fleming; N Datta; R N Grüneberg
Journal:  Br Med J       Date:  1972-03-18
View more
  7 in total

Review 1.  Evolutionary Repair Experiments as a Window to the Molecular Diversity of Life.

Authors:  Thomas LaBar; Yu-Ying Phoebe Hsieh; Marco Fumasoni; Andrew W Murray
Journal:  Curr Biol       Date:  2020-05-18       Impact factor: 10.834

Review 2.  Trimethoprim resistance.

Authors:  P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

3.  A Two-Enzyme Adaptive Unit within Bacterial Folate Metabolism.

Authors:  Andrew F Schober; Andrew D Mathis; Christine Ingle; Junyoung O Park; Li Chen; Joshua D Rabinowitz; Ivan Junier; Olivier Rivoire; Kimberly A Reynolds
Journal:  Cell Rep       Date:  2019-06-11       Impact factor: 9.423

Review 4.  Trimethoprim and sulfonamide resistance.

Authors:  P Huovinen; L Sundström; G Swedberg; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

5.  Comparison of a novel trimethoprim-sulfamethoxazole-containing medium (XT80) with kanamycin agar for isolation of antibiotic-resistant organisms from stool and rectal cultures of marrow transplant patients.

Authors:  D J Hamilton; B K Ulness; L K Baugher; G W Counts
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

6.  High-level resistance to trimethoprim in clinical isolates of Campylobacter jejuni by acquisition of foreign genes (dfr1 and dfr9) expressing drug-insensitive dihydrofolate reductases.

Authors:  A Gibreel; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

7.  Phenotypic and genotypic characterisation of thymine auxotrophy in Escherichia coli isolated from a patient with recurrent bloodstream infection.

Authors:  Aleksandra Jakovljev; Jan Egil Afset; Kjersti Haugum; Harald Otto Steinum; Torunn Gresdal Rønning; Ørjan Samuelsen; Christina Gabrielsen Ås
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.